Status:
COMPLETED
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP
Lead Sponsor:
Inonu University
Conditions:
Hepatocellular Carcinoma
Liver Transplant Disorder
Eligibility:
All Genders
Brief Summary
Retrospective data on 50 prospectively-collected HCC patients with beyond-Milan criteria with \>6cm tumors were analyzed. 5-year OS of 76.2% was found in patients with both AFP \<200 ng/ml and GGT \<1...
Detailed Description
Background:A retrospective analysis was performed of prospectively-collected transplant data on outcomes of patients with large size HCCs,to examine possible prognostically-useful factors.Methods:A to...
Eligibility Criteria
Inclusion
- Liver transplant patients with maximum tumor diameter greater than 6 cm of hepatocellular carcinoma
Exclusion
- Early postoperative mortality (within 90 days)
- Advanced stage tumors (explant patology revealed that tumor continues in the surgical cite such as positive lymph node metastases, macroscopic portal vein trombosis, diaphragmatic invasion, etc)
Key Trial Info
Start Date :
April 19 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04412161
Start Date
April 19 2006
End Date
December 1 2019
Last Update
June 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.